ROSE JULIAN: Open Payments
NPI 1235364530 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,773 in 135 payments from 30 companies in 2025. Trend: 2023 $1,854 · 2024 $3,349 · 2025 $4,773
Food & beverage: $4,674Education: $99
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 14 | $705 |
| Abbott Laboratories | 7 | $422 |
| GlaxoSmithKline, LLC. | 13 | $421 |
| Corcept Therapeutics | 11 | $303 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $264 |
| Dexcom, Inc. | 9 | $251 |
| Lilly USA, LLC | 8 | $242 |
| Inspire Medical Systems, Inc. | 8 | $229 |
| Collegium Pharmaceutical, Inc. | 10 | $194 |
| SANOFI-AVENTIS U.S. LLC | 3 | $176 |
Products named: FREESTYLE LIBRE 3, Korlym, CAPLYTA, MOUNJARO, PENMENVY, INSPIRE, Jornay PM, TRELEGY ELLIPTA.
Industry payments across TX — which companies pay providers there.
